🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this study is to evaluate the efficacy of lurasidone...
Status
Completed
Location
Woodland International Research Group, Inc.
Start Date
2013-05
Trial ID
NCT01821378
The purpose of this study is to evaluate the long-term safety of SM-13496 i...
Status
Completed
Location
Birmingham Psychiatry Pharmaceutical
Start Date
2002-09
Trial ID
NCT00044005
Treatments Being Tested
This is a multi-center, randomized, placebo-controlled, flexible-dose, para...
Status
Completed
Location
Harmonex Neuroscience Research
Start Date
2011-06
Trial ID
NCT01358357
Treatments Being Tested
This is an open-label continuation study designed to monitor the safety, to...
Status
Completed
Location
Okanagan Clinical Trials
Start Date
2011-06
Trial ID
NCT01485640
Treatments Being Tested
Lurasidone HCl is a compound that is a candidate for the treatment of major...
Status
Withdrawn
Location
Birmingham Research Group
Start Date
2012-01
Trial ID
NCT01423240
Treatments Being Tested
This study is an 8-week open-label trial testing Lurasidone (Latuda®) as a ...
Status
Withdrawn
Location
Massachusetts General Hospital
Start Date
2017-01
Trial ID
NCT01932541
Treatments Being Tested
This is a 6 week, randomized, open-label, parallel group study in patients ...
Status
Completed
Location
University of British Columbia, Department of Psychiatry
Start Date
2014-05
Trial ID
NCT02147379
Treatments Being Tested
Lurasidone HCl is a compound that is a candidate for the treatment of major...
Status
Completed
Location
Birmingham Psychiatry Pharmaceutical Studies, Inc
Start Date
2011-09
Trial ID
NCT01423253
Treatments Being Tested
A study to evaluate efficacy and safety of flexibly dosed Lurasidone in chi...
Status
Completed
Location
Harmonex Neuroscience Research
Start Date
2014-03
Trial ID
NCT02046369
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of the drug SM-13496 ...
Status
Completed
Location
Birmingham Psychiatry Pharmaceutical
Start Date
2002-07
Trial ID
NCT00044044
Treatments Being Tested